At the same time, new evidence shows blood–brain-barrier (BBB) changes in obesity (probably similar to BBB alterations in MS), promoting the idea that leptin resistance is caused by the affected transport of leptin at BBB level (Pan and Myers, 2018) [39]. The gene discussed is LEP; the disease is myeloid sarcoma.